Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Estrogen treatment in multiple sclerosis.
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
The challenge of comorbidity in clinical trials for multiple sclerosis.
Iran mass produces MS drug Ziferon
Guillain-Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French Polynesia.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Patterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes Research.
Visualization of myelination in GFP-transgenic zebrafish.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Monoclonal antibodies in MS: mechanisms of action.
Interferon-beta(1b) treatment in neuromyelitis optica.
A gender gap in autoimmunity.
IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.

Pages